These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9826074

  • 1. LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats.
    Konieczny J, Ossowska K, Wolfarth S, Pilc A.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):500-2. PubMed ID: 9826074
    [Abstract] [Full Text] [Related]

  • 2. The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity.
    Wolfarth S, Konieczny J, Lorenc-Koci E, Ossowska K, Pilc A.
    Amino Acids; 2000 Oct; 19(1):95-101. PubMed ID: 11026478
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
    Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, Gueorguieva R, McDougall L, Hunsberger T, Belger A, Levine L, Breier A.
    Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
    [Abstract] [Full Text] [Related]

  • 7. LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine.
    Schreiber R, Lowe D, Voerste A, De Vry J.
    Eur J Pharmacol; 2000 Jan 28; 388(2):R3-4. PubMed ID: 10666513
    [Abstract] [Full Text] [Related]

  • 8. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
    Linden AM, Shannon H, Baez M, Yu JL, Koester A, Schoepp DD.
    Psychopharmacology (Berl); 2005 Apr 28; 179(1):284-91. PubMed ID: 15619115
    [Abstract] [Full Text] [Related]

  • 9. Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats.
    Ossowska K, Konieczny J, Wolfarth S, Wierońska J, Pilc A.
    Neuropharmacology; 2001 Sep 28; 41(4):413-20. PubMed ID: 11543761
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
    Fell MJ, Perry KW, Falcone JF, Johnson BG, Barth VN, Rash KS, Lucaites VL, Threlkeld PG, Monn JA, McKinzie DL, Marek GJ, Svensson KA, Nelson DL.
    J Pharmacol Exp Ther; 2009 Dec 28; 331(3):1126-36. PubMed ID: 19755662
    [Abstract] [Full Text] [Related]

  • 11. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice.
    Popik P, Kozela E, Pilc A.
    Br J Pharmacol; 2000 Jul 28; 130(6):1425-31. PubMed ID: 10903986
    [Abstract] [Full Text] [Related]

  • 12. The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors.
    Ossowska K, Konieczny J, Pilc A, Wolfarth S.
    Brain Res; 2002 Sep 20; 950(1-2):88-94. PubMed ID: 12231232
    [Abstract] [Full Text] [Related]

  • 13. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist.
    Schoepp DD, Johnson BG, Wright RA, Salhoff CR, Monn JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug 20; 358(2):175-80. PubMed ID: 9750002
    [Abstract] [Full Text] [Related]

  • 14. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J, Monn JA, Schoepp DD.
    J Pharmacol Exp Ther; 1999 Oct 20; 291(1):161-70. PubMed ID: 10490900
    [Abstract] [Full Text] [Related]

  • 15. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ, Gasparini F, Markou A.
    J Pharmacol Exp Ther; 2003 Sep 20; 306(3):1068-76. PubMed ID: 12805481
    [Abstract] [Full Text] [Related]

  • 16. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.
    Battaglia G, Monn JA, Schoepp DD.
    Neurosci Lett; 1997 Jul 04; 229(3):161-4. PubMed ID: 9237483
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the mGlu(5) receptor positive allosteric modulator ADX47273 and the mGlu(2/3) receptor agonist LY354740 in tests for antipsychotic-like activity.
    Schlumberger C, Pietraszek M, Gravius A, Klein KU, Greco S, Morè L, Danysz W.
    Eur J Pharmacol; 2009 Nov 25; 623(1-3):73-83. PubMed ID: 19765575
    [Abstract] [Full Text] [Related]

  • 18. A novel orally active group 2 metabotropic glutamate receptor agonist: LY354740.
    Bond A, Monn JA, Lodge D.
    Neuroreport; 1997 Apr 14; 8(6):1463-6. PubMed ID: 9172154
    [Abstract] [Full Text] [Related]

  • 19. Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat.
    Takamori K, Hirota S, Chaki S, Tanaka M.
    Life Sci; 2003 Aug 15; 73(13):1721-8. PubMed ID: 12875903
    [Abstract] [Full Text] [Related]

  • 20. Improved bioavailability of the mGlu2/3 receptor agonist LY354740 using a prodrug strategy: in vivo pharmacology of LY544344.
    Rorick-Kehn LM, Perkins EJ, Knitowski KM, Hart JC, Johnson BG, Schoepp DD, McKinzie DL.
    J Pharmacol Exp Ther; 2006 Feb 15; 316(2):905-13. PubMed ID: 16223873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.